Journal profile · Medicine-Gastroenterology
Portal Hypertension Cirrhosis
ISSN 2770-5838 · eISSN 2770-5846 · Wiley · United Kingdom
Portal Hypertension Cirrhosis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.3 (journal website); fully open access; APC about USD 3,000; median 159 days to acceptance (57 articles, last 24 months); acceptance rate 40% (journal website); 37 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Portal Hypertension Cirrhosis is published by Wiley and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation and Organ Transplantation Techniques and Outcomes, together about 60.5% of its articles. Its main subfields are Hepatology. (generated from OpenAlex topic counts and CAS ranking data)
Portal Hypertension & Cirrhosis (PH&C) is an open access, peer-reviewed journal that aims to publish cutting-edge academic advances on innovative achievements and practice in the field of portal hypertension and cirrhosis. The audience of the journal covers hepatologists, gastroenterologists, endoscopists, digestive surgeons, radiologists, oncologists, etc. PH&C is the official journal of Chinese Portal Hypertension Alliance (CHESS). This title is hosted by Chinese Medical Association (CMA), and supported by National Medical Center for Infectious Diseases of China. Readership: Hepatologists, Gastroenterologists, Endoscopists, Digestive Surgeons, Radiologists, Oncologists, etc. Keywords: Gastroenterology, Hepatology, Portal Hypertension, Cirrhosis, Chronic Liver Disease.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Gastroenterology
Editor-in-chief Xiaolong Qi FounderPublisher website
Editorial board by country: 23 in mainland China (about 36%); most named Mainland China 23, Japan 8, United States 5, Italy 5, Thailand 4 (64 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Liver Disease Diagnosis and TreatmentMedicine26.2%
- Liver Disease and TransplantationMedicine25.9%
- Organ Transplantation Techniques and OutcomesMedicine8.3%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine6.3%
- Nutrition and Health in AgingMedicine3%
- Liver physiology and pathologyMedicine2.3%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance2.3%
- Human auditory perception and evaluationEngineering2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.3Publisher website ·
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- CiteScore (publisher)
- 2.3Publisher website ·
- CiteScore (publisher) 2025
- 2.3Publisher website ·
- SJR 2026-06
- 0.65LetPub ·
- SNIP 2026-06
- 0.29LetPub ·
- h-index
- 9OpenAlex ·
- i10-index
- 9OpenAlex ·
- 2-year mean citedness
- 0.79OpenAlex ·
- Self-citation rate
- 15.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 20LetPub ·
- Articles per year (publisher) 2025
- 28Publisher website ·
- Downloads per year (publisher) 2025
- 160,339Publisher website ·
Articles by year OpenAlex count · 186 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 43 | 43 | 7 |
| 2025 | 37 | 37 | 43 |
| 2024 | 33 | 33 | 39 |
| 2023 | 39 | 39 | 78 |
| 2022 | 34 | 34 | 166 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
159 daysMedian, submission to acceptance · P25–P75 108 days – 234 days
- Acceptance to online
- median 77 days (61 articles)
- Submission to online
- median 229 days
- Sample
- 57 articles with submission and acceptance dates (81 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Acceptance rate (publisher)
- 40%Publisher website ·
- Acceptance rate (publisher) 2025
- 40%Publisher website ·
- Submission to first decision
- 50 daysPublisher website ·
- Submission to first decision 2025
- 50 daysPublisher website ·
- Submission to acceptance 2025
- 156 daysPublisher website ·
- Acceptance to publication 2025
- 67 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,000 / GBP 2,281 / EUR 2,534 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 0 | — | — | |
| LetPub | USD 3,000 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Keywords
- 3–5
- Reference style
- Chicago
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted5, with length limits
- editorialnsolicited editorials are also welcome. Editorials can be up to 2000 words length with no more than 15 references. Word Limit: 2,000 wmain text ≤ 2,000 words
- guidelines-consensus-basedClinical Guidelines are systematically developed, evidence-based/evidence-informed statements and official recommendations. Clinical Guidelines are developed by…Length not stated
- letter to the editorA Letter to the Editor is a brief report that is within the journal's scope and of particular interest to the community, but not suitable as a standard research…Length not stated
- original articleseries, and in vitro study. The text of original articles amounting to about 5,000 words (excluding abstract, references and figures/tables) shouldmain text ≤ 5,000 words
- reviewPortal Hypertension & Cirrhosis (PH&C) uses single-blind peer review process. Submitted manuscripts will generally be reviewed by two or more experts who will b…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Peer review, Plagiarism, Trial registration / reporting guidelines
- Authorship Authorship and Acknowledgements
The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:i. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;ii. Drafting the work or revising it critically for important…
Source ↗Publisher website ·- Conflicts of interest Disclosure
All articles are required to include a disclosure statement. Disclosure should include the following six parts:
Source ↗Publisher website ·- Publication ethics Publication Ethics
Follows COPE core practices Model summary
This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wi…
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html
Source ↗Publisher website ·- Peer review Review Process
Portal Hypertension & Cirrhosis (PH&C) uses single-blind peer review process. Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based …
Source ↗Publisher website ·- Plagiarism
Uses iThenticate CrossCheck for plagiarism detection Model summary
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2770-5838
- Electronic ISSN
- 2770-5846
- Society / sponsor
- Chinese Portal Hypertension Alliance
- Latest issue on the website
- Volume 5, Issue 3 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Portal Hypertension Cirrhosis
What CAS zone is Portal Hypertension Cirrhosis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Portal Hypertension Cirrhosis is in Zone 4 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology / Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Portal Hypertension Cirrhosis?
The journal's website gives an impact factor of 1.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.3, h-index 9.
How long does peer review take at Portal Hypertension Cirrhosis?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 159 days (interquartile range 108–234 days); authors report an average review time of about 12 weeks; the journal's website gives an acceptance rate of 40% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Portal Hypertension Cirrhosis?
According to the journal's author guidelines: Keywords: 3–5; Reference style: Chicago; First submission: Free format: the journal's layout is not required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Portal Hypertension Cirrhosis based?
Of the 64 board members whose country the journal's board page names, 23 (about 36%) are in mainland China; the countries named most often are Mainland China (23), Japan (8) and United States (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Portal Hypertension Cirrhosis?
According to LetPub and DOAJ records, Portal Hypertension Cirrhosis is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and CAS; that list has not been checked against each database.
Is Portal Hypertension Cirrhosis open access, and what is the APC?
Portal Hypertension Cirrhosis is a fully open-access journal. APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .